InvestorsHub Logo
Followers 74
Posts 7298
Boards Moderated 0
Alias Born 09/09/2009

Re: johnglenn post# 9726

Monday, 05/20/2019 4:59:44 PM

Monday, May 20, 2019 4:59:44 PM

Post# of 13091
In my opinion, Mr Chan and company had to take a step back because of all the technological updates they made to the ALRT system, and in doing so, established a new path to success through the USA. I think all that is over with now and we will now start to see market penetration. Read this from the last PR:

"The ALRT Diabetes Solution supplements patient self-management and includes the following additional components essential for effective diabetes treatment:

-The ALRT Diabetes Management Platform enables enterprise-wide prioritization of large diabetes patient populations for timely interventions.
-The ALRT Bluetooth app for iOS, Android, Windows and MacOS simplifies patients uploads of blood glucose data to the platform and then uses MI to provide analysis and diagnostic tools.
-“Best-in-class” blood glucose testing supplies are bundled with the ALRT Diabetes Management Platform that focusses on medication optimization.
-Performance tracking allows care teams to identify areas in treatment plans that require change or improvement

The ALRT Diabetes Solution bundle includes competitively priced blood glucose testing equipment that is fully reimbursable. The Management Platform is included in the bundle at no additional cost. The Company’s target markets include Self-Insured Health Plans in the United States and Government-Funded Health Plans internationally."